141 related articles for article (PubMed ID: 16306781)
1. Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions.
Brustmann H
Int J Gynecol Pathol; 2006 Jan; 25(1):30-7. PubMed ID: 16306781
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB-1 immunoreactivity.
Brustmann H
Int J Gynecol Pathol; 2007 Oct; 26(4):481-9. PubMed ID: 17885502
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of SOX2 in vulvar intraepithelial neoplasia and squamous cell carcinoma.
Brustmann H; Brunner A
Int J Gynecol Pathol; 2013 May; 32(3):323-8. PubMed ID: 23518916
[TBL] [Abstract][Full Text] [Related]
4. Fascin and cyclin D1 immunoreactivity in non-neoplastic vulvar squamous epithelium, vulvar intraepithelial neoplasia and invasive squamous carcinoma: correlation with Ki67 and p16 protein expression.
Stewart CJ; Crook ML
J Clin Pathol; 2014 Apr; 67(4):319-25. PubMed ID: 24218024
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma.
Rufforny I; Wilkinson EJ; Liu C; Zhu H; Buteral M; Massoll NA
J Low Genit Tract Dis; 2005 Apr; 9(2):108-13. PubMed ID: 15870532
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus.
Chiesa-Vottero A; Dvoretsky PM; Hart WR
Am J Surg Pathol; 2006 Mar; 30(3):310-8. PubMed ID: 16538050
[TBL] [Abstract][Full Text] [Related]
7. Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.
Wellenhofer A; Brustmann H
Arch Pathol Lab Med; 2012 Nov; 136(11):1359-65. PubMed ID: 23106581
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A.
Chen H; Gonzalez JL; Brennick JB; Liu M; Yan S
Am J Surg Pathol; 2010 Sep; 34(9):1250-7. PubMed ID: 20697251
[TBL] [Abstract][Full Text] [Related]
9. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
[TBL] [Abstract][Full Text] [Related]
10. immunohistochemical expression of survivin and γ-H2AX in vulvar intraepithelial neoplasia and low-stage squamous cell carcinoma.
Brustmann H; Hinterholzer S; Brunner A
Int J Gynecol Pathol; 2011 Nov; 30(6):583-90. PubMed ID: 21979596
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions.
Rolfe KJ; Crow JC; Benjamin E; Reid WM; Maclean AB; Perrett CW
Int J Gynecol Cancer; 2001; 11(5):381-6. PubMed ID: 11737469
[TBL] [Abstract][Full Text] [Related]
12. Expression of endogenous hypoxia markers in vulvar squamous cell carcinoma.
Li YZ; Li SL; Li X; Wang LJ; Wang JL; Xu JW; Wu ZH; Gong L; Zhang XD
Asian Pac J Cancer Prev; 2012; 13(8):3675-80. PubMed ID: 23098453
[TBL] [Abstract][Full Text] [Related]
13. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
[TBL] [Abstract][Full Text] [Related]
14. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study.
Wu X; Xin Y; Yao J; Hasui K; Tsuyama S; Yonezawa S; Murata F
Med Electron Microsc; 2001 Sep; 34(3):179-84. PubMed ID: 11793194
[TBL] [Abstract][Full Text] [Related]
15. The expression of galectin-1 in vulvar neoplasia.
Kohrenhagen N; Voelker HU; Kapp M; Dietl J; Kämmerer U
Anticancer Res; 2010 May; 30(5):1547-52. PubMed ID: 20592339
[TBL] [Abstract][Full Text] [Related]
16. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
17. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia.
Carlson JA; Ambros R; Malfetano J; Ross J; Grabowski R; Lamb P; Figge H; Mihm MC
Hum Pathol; 1998 Sep; 29(9):932-48. PubMed ID: 9744309
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between the expression of fragile histidine (FHIT) and the development of vulvar carcinoma].
Chu YX; Zheng A; Xi MR; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):218-20. PubMed ID: 16608079
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva.
Santos M; Montagut C; Mellado B; García A; Ramón y Cajal S; Cardesa A; Puig-Tintoré LM; Ordi J
Int J Gynecol Pathol; 2004 Jul; 23(3):206-14. PubMed ID: 15213596
[TBL] [Abstract][Full Text] [Related]
20. Keratin expression in normal vulva, non-neoplastic epithelial disorders, vulvar intraepithelial neoplasia, and invasive squamous cell carcinoma.
Esquius J; Brisigotti M; Matias-Guiu X; Prat J
Int J Gynecol Pathol; 1991; 10(4):341-55. PubMed ID: 1723057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
